Cargando…
Changes in labelling for metformin use in patients with type 2 diabetes and heart failure: documented safety outweighs theoretical risks
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Open Medicine Publications, Inc.
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205816/ https://www.ncbi.nlm.nih.gov/pubmed/22046218 |
| _version_ | 1782215368728641536 |
|---|---|
| author | Eurich, Dean T Majumdar, Sumit R McAlister, Finlay A Tsuyuki, Ross T Johnson, Jeffrey A |
| author_facet | Eurich, Dean T Majumdar, Sumit R McAlister, Finlay A Tsuyuki, Ross T Johnson, Jeffrey A |
| author_sort | Eurich, Dean T |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3205816 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | Open Medicine Publications, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-32058162011-11-01 Changes in labelling for metformin use in patients with type 2 diabetes and heart failure: documented safety outweighs theoretical risks Eurich, Dean T Majumdar, Sumit R McAlister, Finlay A Tsuyuki, Ross T Johnson, Jeffrey A Open Med Clinical Practice Open Medicine Publications, Inc. 2011-02-22 /pmc/articles/PMC3205816/ /pubmed/22046218 Text en http://creativecommons.org/licenses/by-nc-sa/2.5/ca/ Open Medicine applies the Creative Commons Attribution Share Alike License, which means that anyone is able to freely copy, download, reprint, reuse, distribute, display or perform this work and that authors retain copyright of their work. Any derivative use of this work must be distributed only under a license identical to this one and must be attributed to the authors. Any of these conditions can be waived with permission from the copyright holder. These conditions do not negate or supersede Fair Use laws in any country. |
| spellingShingle | Clinical Practice Eurich, Dean T Majumdar, Sumit R McAlister, Finlay A Tsuyuki, Ross T Johnson, Jeffrey A Changes in labelling for metformin use in patients with type 2 diabetes and heart failure: documented safety outweighs theoretical risks |
| title | Changes in labelling for metformin use in patients with type 2 diabetes and heart failure: documented safety outweighs theoretical risks |
| title_full | Changes in labelling for metformin use in patients with type 2 diabetes and heart failure: documented safety outweighs theoretical risks |
| title_fullStr | Changes in labelling for metformin use in patients with type 2 diabetes and heart failure: documented safety outweighs theoretical risks |
| title_full_unstemmed | Changes in labelling for metformin use in patients with type 2 diabetes and heart failure: documented safety outweighs theoretical risks |
| title_short | Changes in labelling for metformin use in patients with type 2 diabetes and heart failure: documented safety outweighs theoretical risks |
| title_sort | changes in labelling for metformin use in patients with type 2 diabetes and heart failure: documented safety outweighs theoretical risks |
| topic | Clinical Practice |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205816/ https://www.ncbi.nlm.nih.gov/pubmed/22046218 |
| work_keys_str_mv | AT eurichdeant changesinlabellingformetforminuseinpatientswithtype2diabetesandheartfailuredocumentedsafetyoutweighstheoreticalrisks AT majumdarsumitr changesinlabellingformetforminuseinpatientswithtype2diabetesandheartfailuredocumentedsafetyoutweighstheoreticalrisks AT mcalisterfinlaya changesinlabellingformetforminuseinpatientswithtype2diabetesandheartfailuredocumentedsafetyoutweighstheoreticalrisks AT tsuyukirosst changesinlabellingformetforminuseinpatientswithtype2diabetesandheartfailuredocumentedsafetyoutweighstheoreticalrisks AT johnsonjeffreya changesinlabellingformetforminuseinpatientswithtype2diabetesandheartfailuredocumentedsafetyoutweighstheoreticalrisks |